Cytokines.
Holmlund
J T
JT
Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research and Development Center, MD.
D002986:Clinical Trials as Topic; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D016219:Immunotherapy, Adoptive; D007372:Interferons / Q000627:therapeutic use; D007375:Interleukin-1 / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D016207:Cytokines; D007375:Interleukin-1; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons